Boston Scientific Corp., 10% Owner at Pulmonx Corp (LUNG), sold 2,500,000 shares at $37.45 ($93.6M) on 2021-07-13, disclosed to the SEC on 2021-07-14.
Open-market sale of $93.6M LUNG by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| Filing → |
| IMRX | SELL | 2008-09-19 | $400K | — | Filing → |
| CYBX | SELL | 2007-10-05 | $48.6M | — | Filing → |
| NSTR | SELL | 2007-07-26 | $32.5M | — | Filing → |